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Abstract 
A 33-year-old primigravida presented to an appointment at a high-risk pre-
natal outpatient service due to a history of splenomegaly. Her spleen occupied 
2 3  of the abdominal cavity and shifted the uterus to the right side of the 
abdomen. During investigation, an intrauterine growth restriction (IURG) 
and a series of other clinical complications were discovered. We admitted her 
to inpatient care at 28 + 1 weeks’ gestation for a better investigation of her ex-
tensive splenomegaly and for pregnancy monitoring, with a further successful 
delivery. 
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1. Introduction 
Splenomegaly can be a clinical sign of many systemic diseases, the most com-
mon cases being liver diseases, hematologic malignancies, infections (such as 
AIDS, endocarditis and parasitosis) and congestion or inflammation (such as in 
congestive heart failure) [1]. Patients with splenomegaly may be asymptomatic. 
Nevertheless, these patients sometimes report abdominal pain or even present a se-
ries of other clinical manifestations depending on the specific cause of this finding. 
Once the etiology is known, we can choose a better treatment for such patients. 
How to cite this paper: Vettorazzi, J., 
Valério, E.G., Reis, A.R., Torres, H.F.I. and 
Petermann, A. (2018) Massive Splenome-
galy in Pregnancy: Case Report. Open 
Journal of Obstetrics and Gynecology, 8, 
163-169. 
https://doi.org/10.4236/ojog.2018.83019  
 
Received: December 11, 2017 
Accepted: March 3, 2018 
Published: March 6, 2018 
 
Copyright © 2018 by authors and  
Scientific Research Publishing Inc. 
This work is licensed under the Creative 
Commons Attribution International  
License (CC BY 4.0). 
http://creativecommons.org/licenses/by/4.0/   
  Open Access
J. Vettorazzi et al. 
 
 
DOI: 10.4236/ojog.2018.83019 164 Open Journal of Obstetrics and Gynecology 
 
In the pregnant population, splenomegaly may represent a risk for both the 
mother and the fetus [2]. There is a vast amount of information on the specific 
management of the diseases causing splenomegaly and other splenic disorders 
during pregnancy, but there is little information regarding the obstetric aspects 
of pregnant women with splenomegaly. In this article, we present a case of a 
pregnant patient whose splenomegaly had no defined etiology after a large in-
vestigation with a multidisciplinary team of doctors and aim to discuss the pa-
tient’s obstetric approach and the management of a series of other findings. 
2. Case 
A 33-year-old primigravida from southern Brazil presented to her first obstetric 
appointment at our high-risk prenatal outpatient service at 21 + 2 weeks’ gesta-
tion due to a history of splenomegaly. She learned of her increased spleen size 
when she was 19 years old during the physical examination at a medical ap-
pointment for an abdominal pain crisis and further learned that she also had in-
ferior vena cava atresia. With no clear indication for surgery, the patient re-
ceived pain medications such as Paracetamol and her condition was hencefor-
ward followed up by her general physician. 
She reported many years of continuous hypochondriac pain and chronic 
anaemia, denying a history of weight loss, fever, nocturnal sweating or any other 
symptoms. She also reported a previous extensive investigation for infectious 
causes of splenomegaly, the results of which were all negative. 
Her gynecological exam showed a fundal height of 20 cm and a fetal heart rate 
of 147 bpm. Her spleen was palpable down to the left iliac fossa, but there were 
no palpable adenomegalies. Otherwise, her physical exam was unremarkable. 
She was Caucasian, a previous tobacco user who stopped smoking before ges-
tation and had no previous surgeries. She denied previous travels to northern 
Brazil, where Malaria, Leishmaniasis and other parasitoses are endemic. 
One day before hospitalization, the patient underwent an abdominal ultra-
sound (Figure 1), which presented the findings of chronic thrombosis of the left 
branch of the portal vein and of the splenic vein with collateral circulation, signs 
suggestive of chronic liver disease, a spleen measuring 33 cm in diameter at its 
largest point and normal blood flow in the inferior vena cava. The patient was 
then admitted to inpatient care at 28 + 1 weeks’ gestation for a better investiga-
tion of her extensive splenomegaly and chronic thrombosis in both portal and 
splenic veins and for pregnancy monitoring. On admission, the patient had a 
body mass index (BMI) of 20.6 kg/m2 and presented with massive splenomegaly 
at the physical examination, with the spleen occupying roughly 2 3  of the ab-
dominal cavity, as seen on Figure 2, and pelvis and shifting the uterus to the 
right side of the abdomen. Laboratory values on her first day at the hospital were 
hemoglobin 9.5 mg/dL (normal range: 11.5 - 16.0 mg/dL), total leukocytes 
6120/mm3 (normal range: 4000 - 10,000 mm3), platelet count 132,000/mm3 
(normal range: 150,000 - 400,000 mm3), AST 18U/L (normal range: 0 - 32 U/L) 
and ALT 17 U/L (normal range: 0 - 33 U/L). The results of an investigation for  
J. Vettorazzi et al. 
 
 
DOI: 10.4236/ojog.2018.83019 165 Open Journal of Obstetrics and Gynecology 
 
 
Figure 1. Abdominal Ultrasound: (a) Only the right branch of the portal vein can be seen in the image, suggesting chronic 
thrombosis of the left branch; (b) Dilation of the portal vein (1, 4 cm of diameter); (c) The enlarged spleen measures 33 cm on its 
largest longitudinal axis; (d) Inferior vena cava—no significant alterations. 
 
 
Figure 2. A drawing on the patient’s abdomen corresponding to the approximate 
size of her spleen. 
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causes of thrombophilias (factor V Leiden, C protein, prothrombin mutation and 
anticardiolipin IgM and IgG) were negative. Test results for ANA, anti-DNA, 
lupic anticoagulant, rheumatoid factor, C 3 and C 4, antithrombin activity and 
paroxysmal nocturnal hemoglobinuria were also negative. The patient tested 
negative for infectious hepatitis and HIV. The JAK 2 mutation was present, but 
the patient had no clinical manifestation of myeloproliferative diseases other 
than splenomegaly. She underwent bone marrow biopsy, which presented only 
reactional abnormalities and megakaryocyte hyperplasia, and her medulogram 
presented hyperplasia of all blood cell lineages. Her echocardiography had no 
significantly altered findings and the abdominal presentations at successive abdominal 
ultrasounds remained unchanged during the entire hospitalization period. 
During her inpatient care period, she was evaluated intensely by doctors of 
many specialities. The hematology team conducted an extensive investigation 
concerning the origin of the patient’s chronic thrombosis and splenomegaly, 
which produced no clear answer after 2 months of multiple examinations. 
Surgeons also evaluated the patient and saw no indication for splenectomy, as 
the patient was clinically stable. The gastroenterology service did not indicate a 
new upper gastrointestinal endoscopy, because the patient had already under-
gone the same procedure, which showed the presence of small esophageal varic-
es justifying that a new exam would only aggravate the risk at that moment and 
indicated the prescription of propranolol for primary bleeding prophylaxis. The 
multidisciplinary team formed by hematologists, general surgeons, vascular 
surgeons, gastroenterologists and obstetricians opted to maintain heparin in 
prophylactic doses and not administer full-dose therapy during the hospitaliza-
tion period, given the patient’s risk of upper digestive bleeding due to her eso-
phageal varices. 
She was evaluated during her entire inpatient period with periodic fetal as-
sessment and weekly Doppler ultrasonography due to intrauterine growth re-
striction, with Doppler demonstrating distention of the middle cerebral artery 
and normal umbilical arteries. We opted to electively interrupt gestation at 36 
weeks by cesarean section, given the risks of bleeding during an exposure ma-
neuvre of a vaginal delivery, because the spleen occupied a wide portion of her 
pelvis and had dislocated the uterine body and due to restricted fetal growth 
(percentile 5); before surgery, the patient had a hemoglobin level of 10.5 mg/dL 
and a platelet count of 178,000/m3 so a reservation of blood supply was re-
quested. A xifopubic median abdominal incision and broad fundic/body uterine 
incision were then performed and a female baby was born weighing 2255 g with 
an Apgar score of 8/9; no complications occurred during the surgery and blood 
supply was not necessary. The possibility of performing a concomitant sple-
nectomy during the cesarean section, which could increase the risk of maternal 
morbidity but might be necessary, was discussed with the surgical team. The 
findings of the surgery are described on Figure 3 and Figure 4. The general 
surgeons were therefore present in the operating room during the cesarean sec-
tion, but the splenectomy was not necessary as the patient had no significant 
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bleeding during the surgical procedure. The patient evolved to a physiologic pu-
erperium and the baby was discharged from the hospital with the mother 4 days 
after delivery. 
The patient returned 5 days after being discharged from the hospital for an 
appointment with the obstetrics team and received an anticoagulant prescription 
with directions of continuing an outpatient investigation of the etiology of her 
splenomegaly with the hematology team, as there was no final diagnosis for this 
 
 
Figure 3. The patient’s spleen shown clearly (blue arrow). 
 
 
Figure 4. During surgery, the enlarged spleen (blue arrow) occupied most of the left por-
tion of the patient’s abdomen, prominent mesenteric vascularization (yellow Arrow) was 
noticed and a suture of the uterine fund (white arrow) was preformed where the fetus was 
removed. 
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presentation. Around 40 days after delivery, the patient had a copper intraute-
rine device (IUD) implanted. The hematology team continued to investigate the 
uncertain etiology of her splenomegaly. The patient signed an informed consent 
authorizing the publication of this case. 
3. Discussion 
There are many known causes of splenomegaly during pregnancy, which do not 
differ much from those in the general population. However, the management of 
a patient with a voluminous splenomegaly of unknown etiology can be chal-
lenging, especially when it involves a pregnant woman, as it may bring a series of 
risks and complications for both the mother and the fetus. Most articles discuss 
the best therapy for certain diseases that cause splenomegaly specifically during 
the pregnancy period, but there is little information regarding the obstetric ap-
proach to cases where extensive splenomegaly may be a potential obstetric issue. 
In the general population, an enlarged spleen may increase the risk of infec-
tions, bleeding secondary to splenic sequestration of platelets and traumatic or 
spontaneous splenic rupture, complications that can also affect pregnant women 
with splenomegaly. In addition, some authors believe pregnancy itself may be a 
risk factor for splenic rupture, an event that can be fatal for both the mother and 
the child if misdiagnosed [2]. Despite being extremely rare, there are reported 
cases of spontaneous splenic rupture during pregnancy with no underlying pa-
thology or trauma history that could explain this event, but trauma continues to 
be the major cause of splenic rupture [3]. 
Another remarkable finding in this case was the fetus’s restricted intrauterine 
growth. Since the patient’s prenatal infection screening results were negative, no 
signs of other systemic or obstetric diseases were present and the anatomopa-
thological exam of the placenta was normal, we can point to two possible causes 
of this disturbance in this patient among the most common etiologies of IURG: 
First is the mother’s chronic morbidity, given that she had a long history of 
anaemia and splenomegaly of unknown etiology; Secondly, the mother’s spleen 
occupied a large space in her abdomen and pelvis, and this might have played a 
role in the development of the fetus’s IURG, although there is no clear evidence 
of the correlation between these two events. 
Despite the potential complications during delivery due to splenomegaly, the 
best mode of delivery in patients with this finding is not yet established. In a re-
cent prospective cohort study from the United Kingdom that evaluated preg-
nancy outcomes in patients with myeloproliferative neoplasms who have sple-
nomegaly as a relatively frequent finding [4], the rate of cesarean delivery was 
45% [5]. The study does not point to splenomegaly itself as a deciding factor in 
the mode of delivery; therefore, it is not known whether this finding might have 
played a role in choosing the route of birth. In our patient’s case, the considera-
ble volume of the spleen supported the decision to deliver by cesarean section, 
because the uterus was dislocated by the spleen to the right side of the abdomen, 
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and the spleen itself occupied a portion of the pelvis. Hence, we believe physi-
cians should evaluate each case individually to determine which mode of deli-
very is best for their pregnant patients with splenomegaly. 
This case also highlights the importance of a multidisciplinary team to discuss 
the best approach to patients with a clinical finding with no defined etiology and 
a series of clinical complications. In our patient’s case, a group formed by doc-
tors from different specialities had to weigh the risks and benefits of full anti-
coagulation, as the patient had simultaneous thrombotic findings and esopha-
geal varices. Heparin was eventually prescribed in prophylactic doses because 
the team believed that the risks of bleeding complications surpassed the benefits 
of full anticoagulation in this pregnant patient. The patient participated actively 
in all the clinical decisions and was continuously informed about her clinical 
status. 
We must ultimately remember the importance of discussing contraception 
methods with all patients before and after their delivery, offering them complete 
gynecological care. 
4. Conclusion 
Splenomegaly, regardless of its etiology, may be an issue during pregnancy, 
representing risks for both the mother and the child. We lack evidence regarding 
the best obstetric approach for pregnant patients with splenomegaly. In order to 
offer the best medical care for these patients, they should be evaluated by a mul-
tidisciplinary team. 
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